Home / Health / Advisory Panel Drops Opposition to mRNA Vaccines
Advisory Panel Drops Opposition to mRNA Vaccines
11 Mar
Summary
- Federal vaccine panel ceases efforts against mRNA COVID vaccines.
- HHS unit under RFK Jr. previously sought to halt mRNA vaccine development.
- Advisers will meet next week to recommend vaccine guidelines.
A significant U.S. federal vaccine advisory panel has reportedly ended its efforts to oppose mRNA COVID vaccines. This development was revealed by the Washington Post, citing individuals familiar with the matter.
Previously, some vaccine advisers within the Health and Human Services (HHS) department, under the leadership of Secretary Robert F. Kennedy Jr., had pursued a plan to potentially halt recommendations for mRNA shots. However, this initiative is no longer proceeding.
The HHS, which oversees the Centers for Disease Control and Prevention (CDC), had announced in August of the previous year its decision to cease mRNA vaccine development activities within its biomedical research unit. This decision was reportedly based on Secretary Kennedy Jr.'s assertion that these vaccines failed to effectively protect against upper respiratory infections.
The advisory committee to the CDC is set to convene next week. During this meeting, they are expected to issue recommendations regarding the vaccines Americans should utilize and the appropriate timing for their administration. These vaccines, developed by Pfizer-BioNTech and Moderna, function by instructing cells to produce a viral protein, thereby stimulating immunity without using weakened or inactivated viruses.
